Denial of doses to persons without IDs, absence of segregated data and low awareness pose question mark on campaign
In a Q&A, Rehan A Khan talks about his firm's strong focus on R&D and its commitment to making drugs affordable
Covaxin has a shelf life of 12 months, while Covishield, the vaccine that accounted for nearly 80% of India's vaccinations, has a shelf life of nine months
'Vaccine equity not possible if we include imported mRNA vaccines in our programme', said Arora
On May 4, Biological E submitted an application seeking emergency use authorisation for its Covid vaccine Corbevax as a booster dose in adults fully vaccinated with Covishield or Covaxin
A study found that a booster shot different from the primary vaccines, such as Covishield or Covaxin, did not produce satisfactory results
DCGI has granted emergency use authorisation for Biological E's Covid-19 vaccine Corbevax and Bharat Biotech's Covaxin
With 2,483 new coronavirus infections being reported in a day, India's total tally of COVID-19 cases rose to 4,30,62,569, while the active cases dipped to 15,636.
The Ministry of Health and Family Welfare informed on Sunday that over 1.9 billion of Covid-19 vaccine doses have been provided to States and Union Territories so far.
Private channel alone will not be enough
The Health Ministry on Saturday informed that over 17.54 crore unutilized Covid-19 vaccine doses are still available with the states and Union Territories (UTs) to be administered.
Vaccination programme cannot lose govt attention
Over 1.59 crore (1,59,51,459) vaccine doses have so far been administered to beneficiaries in the age group of 12-14 years
The country launched vaccination for all people aged above 45 years from April 1 last year
The vaccine has not been included in the country's inoculation programme against Covid-19
Covid-19 still remains a big risk
The Central Drugs Standard Control Organization in consultation with Subject Expert Committee has approved four COVID-19 vaccines for restricted use in emergency situation for those aged below 18 years, the Rajya Sabha was informed on Tuesday. The four vaccines which have been approved are Zydus Cadila's ZyCovD (in the age group of 12 years and older), Bharat Biotech's Covaxin (for >2 to <18 years age group), Biological E's Corbevax (for =5 to <18 years age group) and Serum Institute of India's Covovax (for >12 to <18 years age group), Minister of State for Health Bharati Pravin Pawar said in a written reply. The National COVID-19 vaccination programme was expanded to include adolescents aged 15 to 18 years from January 3, 2022. It was further expanded to children of age group 12 -14 years from March 16. The National Covid vaccination programme is guided by National Technical Advisory Group on Immunization (NTAGI) and the National Expert Group on Vaccine ...
The first day of the Covid vaccination drive for 12-14 year-old children saw a lukewarm response with the vaccinators hoping for a better turnout during the weekend when the schools are closed.
Vaccination of children in the age group of 12-14 years began in Maharashtra with the state government directing officials to hold ten dedicated sessions in each district to administer the doses.
A third shot that does not match the first two doses may be allowed